OPTIMI HEALTH CORP

OPTHNASDAQ

Earnings Sep 7US Equity

$4.68▼ $0.18 (−3.90%)

🌅 Pre-market$4.86▲ 3.85%Regular close · extended-hours price shown

1h—

24h▼ 3.9%

7d▼ 6.7%

14d▼ 1.6%

30d▼ 0.6%

1y—

🏦Market Cap

$27M

Small Cap

📈Revenue Growth (YoY)

-40.3%

Declining

📊Gross Margin

91.7%

High

💵FCF Margin

—

⚖️P/S Ratio

131.6x

Expensive

Otter Score

Fair

Trading Snapshot

Day Range: $4.63 – $4.75
52-Week Range: —
Volume: $2.61B
Avg Volume: $3.22B
Shares Outstanding: 5.7M
Next Earnings: Oct 26, 2026

Fundamentals Snapshot

Annual Revenue: $426,904
Last Q Revenue: $99,500
P/E Ratio: —
P/S Ratio: 131.6x
EPS (TTM): —
Dividend Yield: —

Why Investors Own OPTH

✓High-growth profile — revenue up +48.4% YoY with expanding US Equity exposure.
✓Healthy economics — 53% gross margin and 11% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$426,904▲ +43.8% YoY

Gross Margin (TTM)

53.2%▲ +1.7% YoY

Operating Income (TTM)

$76,416▲ +43.8% YoY

Free Cash Flow (TTM)

$46,959▲ +43.8% YoY

About OPTIMI HEALTH CORP

Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

🦦